
|Articles|December 5, 2022
Optimizing Choice, Flexibility and Outcomes With Patient-First Data Collection for Oncology
Author(s)Medable
Traditionally, Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, we have a more effective, patient-first solution. Optimize patient choice, improve retention and safety with Patient- First Oncology solutions that meet patients where they are.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
2
Audits, Inspections, and CDMOs
3
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
4
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
5
